Analysis for CRH
- 📈 Growth — 26/30
- 💰 Profitability — 14/20
- 🏦 Financial Health — 15/20
- 💵 Valuation — 12/20
- ⚠️ Risk — 6/10
Summary:
📈 Growth & Financial Trajectory
Over the eight quarters, CRH Public's revenue rose from $6.53B in 2024 Q1 to about $9.42B in 2025 Q4, a gain of roughly $2.89B (~44%). Net income progressed from $114M to about $1.04B by year-end, though 2025 Q1 was negative (-$98M). The trend shows resilience with a mid-2025 rebound, as Q2–Q3 2025 delivered stronger top-line growth and improved profitability, then carried into year-end.
The eight-quarter sequence displays quarterly volatility, but the late-2025 data indicate sustained momentum in both revenue and earnings.
💰 Margins & Cash Flow
Gross margins have generally ranged from the mid-30s to low-40s across quarters, with Q2–Q3 2024 near 41% and Q4 2025 around 35–36%. Operating cash flow was positive in most periods, with Q4 2025 showing a robust run of about $2.92B from operations. Investing cash flow was consistently negative, and financing activity fluctuated, contributing to a mixed but generally stable cash trajectory.
🛡️ Balance Sheet & Liquidity
Total assets have hovered in the high tens of billions, with Assets ~$58B at year-end 2025, liabilities around $32B and equity near $24B. The current ratio sits above 1.0 (roughly 1.3x), supporting liquidity and resilience through cycle dips.
⚠️ Key Drivers & Risks
- Drivers: Revenue scale, consistent gross margin leverage, and cash-flow generation.
- Risks: Quarterly earnings volatility and sensitivity to input costs/debt levels.